Data as of Oct 01
| -0.65 / -1.27%|
The 17 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 56.00, with a high estimate of 60.00 and a low estimate of 34.00. The median estimate represents a +10.83% increase from the last price of 50.53.
The current consensus among 22 polled investment analysts is to Hold stock in Bristol-Myers Squibb Co. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.